Alpha synuclein PET imaging, a step closer to in vivo neuropathology in Parkinson's disease and related disorders

Michele Matarazzo,José A Obeso
DOI: https://doi.org/10.1016/j.neuron.2024.07.001
IF: 16.2
2024-08-07
Neuron
Abstract:In this issue of Neuron, Endo et al.1 develop a PET tracer capable of detecting alpha-synuclein (ɑ-syn). With validation in animal models and humans, this tracer brings us closer to being able to monitor the synuclein aggregation process and associated pathological changes in Parkinson's disease (PD) and other synucleinopathies.
What problem does this paper attempt to address?